Sandra Levy
ARTICLES BY THIS AUTHOR
- 9/30/2020
APhA, Washington State University launch program to prepare pharmacists for pediatric immunizations
The new program is aimed at preparing state-licensed immunizing pharmacists to meet the education requirements to administer vaccinations to children age 3 to 18 years old. - 9/29/2020
Hy-Vee pharmacies offer childhood vaccinations, flu shots
Childhood vaccinations now are available at more than 270 Hy-Vee pharmacy locations in eight states. - 9/29/2020
Schnuck Markets deploys Tally robot to more locations
Schnuck Markets is launching Simbe Robotics’ technology in an additional 46 stores, leveraging Tally’s real-time data to improve the shopping experience in 62 locations. - 9/28/2020
GSK gets FDA blessing for new indication for Nucala
GSK’s Nucala has received the Food and Drug Administration’s approval for patients with HES, a group of rare blood disorders. - 9/28/2020
Dr. Reddy's debuts Tecfidera generic
The Tecfidera brand and generic had a market value of roughly $3.8 billion for the most recent 12 months ended June 2020, according to IQVIA. - 9/28/2020
AAM report: Generic savings totaled $313B in 2019
The U.S. healthcare system saved $313 billion in 2019 due to low-cost generics, according to a new report by the Association for Accessible Medicines. - 9/28/2020
Teva offers generic Tecfidera
Teva’s generic is available in dosage strengths of 120 mg and 240 mg, as well as in bottle sizes of 14 capsules and 60 capsules, respectively. - 9/28/2020
NACDS flu ads to air during presidential debate week in Washington, D.C.
The National Association of Chain Drug Stores’ flu vaccine message will air in Washington, D.C., on presidential debate day and debate reaction day. - 9/24/2020
FDA finalizes rule for Canadian drug importation
As part of the President’s plan, on Thursday, HHS issued a final rule to implement a provision of the Federal Food, Drug, and Cosmetic Act to allow the importation of certain prescription drugs from Canada. - 9/24/2020
Dr. Reddy's launches generic Precedex
Brand and generic sales for Precedex in 0.9% sodium chloride injection were $210 million for the most recent 12 months ended June 2020, according to IQVIA.
